CI
Cigna Group
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 296.27
Buy <=wait / entry
USD 256.67
Trim >=take some off
USD 300.00
Thesis breakMaterial adverse PBM legislation or binding regulation that structurally compres...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 43% | 100 / 100 | 43.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 8% | 10 / 100 | 0.8 |
| Weighted conviction | 74 / 100 - BUY | ||
Top risks
- Q4 2025 adjusted EPS of $8.08 beat estimates by 5.65% with revenue of $72.47B exceeding estimates by 9.17%
- Raised 2026 full-year adjusted EPS guidance to at least $30.45 following Q2 2026 results of $7.78
- Investor Day 2026 announcement of 'Lead to One' strategy with $3B modernization initiative targeting 10-14% adjusted EPS CAGR through 2030 and $50B cumulative operating cash flow